Unicornshell
Company News
Company News
Leading capsule innovation, foreseeing the industry's future.
Craftsmanship Builds Dreams! Honored as a 2025 Model Worker of Qiqihar City. Leading the high-quality development of HPMC pharmaceutical excipients through technological innovation.
Publication Date:2025.06.09
Share:

On June 6, 2025, Qiqihar City held a grand commendation conference for the 2025 Model Workers and May Day Labor Awards. Wang Qiju, General Manager of the Heilongjiang subsidiary of Shanghai Unicornshell Pharmaceutical Technology Co., Ltd., was honored with the title of "Model Worker of Qiqihar City". This award not only recognizes his outstanding management capabilities but also highlights the municipal government's high regard for Unicornshell's HPMC material empty capsule project and its full recognition of the company's innovative achievements in the field of HPMC pharmaceutical excipients.



As a key implementer of Unicornshell's national strategic layout, Comrade Wang Qiju led his team to overcome difficulties and efficiently advance the construction of the HPMC empty capsule production base. The project is expected to go into production by the end of 2025, becoming an important milestone in the company's national strategic deployment. Comrade Wang Qiju's award is not only a personal honor but also the crystallization of the concerted and diligent efforts of the entire Unicornshell team.



Unicornshell remains committed to the mission of "promoting medication safety and protecting human health", focusing on the R&D of HPMC empty capsules and the transformation of modern traditional Chinese medicine (TCM) projects. The company has built a full‑chain innovation system covering raw material breeding and cultivation, process optimization, and industrial application, enabling integrated development of agriculture, industry, and rural revitalization. Its self‑developed plant‑derived pharmaceutical excipient solutions not only fill the domestic technological gap in HPMC empty capsules but also establish a Chinese brand as a technical benchmark in the global HPMC pharmaceutical excipient segment.



This recognition has greatly boosted the morale of all Quanjikang employees. Going forward, the company will be guided by the spirit of model workers, accelerate the dual‑engine strategy of "HPMC Pharmaceutical Excipients R&D Center" and "Modern TCM Industrial Base", inject green momentum into the pharmaceutical and health industry through continuous technological innovation, and export sustainable development solutions made with Chinese intelligence to the world.

Copyright © Unicornshell Pharmaceutical Technology Co., Ltd. All Rights Reserved Powered by Raise